News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>CMSI Rates LI NING as Overweight; 1Q Sell-Through Growth In Line With Full-Yr Target
LI NING (02331.HK) recorded mid-single-digit YoY growth in overall retail sell-through in 1Q26, CMSI said in a research report. The growth stood on a low-double-digit increase in t...
Reset
Send
The window will close in 5 seconds
<Research>CMSI Rates LI NING as Overweight; 1Q Sell-Through Growth In Line With Full-Yr Target
Close
Recommend
7
Positive
2
Negative
6
 
 

LI NING (02331.HK)  0.000 (0.000%)    Short selling $55.38M; Ratio 25.690%   recorded mid-single-digit YoY growth in overall retail sell-through in 1Q26, CMSI said in a research report. The growth stood on a low-double-digit increase in the direct-operated channel and a high-single-digit increase in the e-commerce channel, while the wholesale channel posted a low-single-digit increase.

Including around 20% growth in the kidswear business, LI NING's overall reported retail sell-through growth reached high-single-digit levels, in line with the full-year target.

CMSI gave LI NING a target price of HKD23.5 and an Overweight rating.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-22 16:25.)

Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.